These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3497884)

  • 41. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones.
    Blanchard D; van Els C; Borst J; Carrel S; Boylston A; de Vries JE; Spits H
    J Immunol; 1987 Apr; 138(8):2417-21. PubMed ID: 3104466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptors.
    Rodolfo M; Castelli C; Bassi C; Accornero P; Sensi M; Parmiani G
    Int J Cancer; 1994 May; 57(3):440-7. PubMed ID: 8169008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxic T lymphocyte-mediated lysis via the Fc receptor of target cells.
    Staerz UD; Bevan MJ
    Eur J Immunol; 1985 Dec; 15(12):1172-7. PubMed ID: 2935404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.
    Liu MA; Kranz DM; Kurnick JT; Boyle LA; Levy R; Eisen HN
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8648-52. PubMed ID: 3936039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen recognition by H-2-restricted cytolytic T lymphocytes is not mediated by two independent receptors.
    Harris DT; MacDonald HR; Cerottini JC
    J Exp Med; 1984 Jan; 159(1):330-5. PubMed ID: 6198426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
    Tutt A; Stevenson GT; Glennie MJ
    J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct.
    Hoffmann P; Hofmeister R; Brischwein K; Brandl C; Crommer S; Bargou R; Itin C; Prang N; Baeuerle PA
    Int J Cancer; 2005 May; 115(1):98-104. PubMed ID: 15688411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis.
    Braakman E; Goedegebuure PS; Vreugdenhil RJ; Segal DM; Shaw S; Bolhuis RL
    Int J Cancer; 1990 Sep; 46(3):475-80. PubMed ID: 1975566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance of cytotoxic T lymphocytes to lysis by a clone of cytotoxic T lymphocytes.
    Kranz DM; Eisen HN
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3375-9. PubMed ID: 2953028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation of targets for alloreactive CTL using purified H-2Kk in liposomes and polyethylene glycol.
    Reed ML; Herrmann SH
    Mol Immunol; 1986 Dec; 23(12):1339-47. PubMed ID: 3493426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
    Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
    Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14.
    Seth A; Gote L; Nagarkatti M; Nagarkatti PS
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7877-81. PubMed ID: 1881921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo.
    Moreno MB; Titus JA; Cole MS; Tso JY; Le N; Paik CH; Bakács T; Zacharchuk CM; Segal DM; Wunderlich JR
    Cancer Immunol Immunother; 1995 Mar; 40(3):182-90. PubMed ID: 7728777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR; Koszinowski UH; Eichmann K; Melchers I
    J Immunol; 1989 Dec; 143(12):4238-43. PubMed ID: 2556481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.